This inventor holds 2 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1981-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sengokuhigashimachi, JP (1981)
- Sengokuhigashi, JP (1987)
Company Filing History:
Years Active: 1981-1987
Title: Yoichi Sawa: Innovator in Osteoporosis Treatment and Chemical Production
Introduction
Yoichi Sawa, an accomplished inventor based in Sengokuhigashimachi, Japan, has made significant contributions to the fields of medicine and chemistry. With a total of two patents, Sawa's work focuses on innovative treatments and the production of valuable chemical compounds.
Latest Patents
One of Sawa's latest patents is a treatment for osteoporosis, which involves a compound with the formula ##STR1##. This compound demonstrates effectiveness in the prevention or treatment of osteoporosis, with components where R^1 can be hydrogen or hydroxy, R^2 and R^3 are independently hydrogen or lower alkyl, and Y is carboxyl or a group convertible to carboxyl.
Additionally, Sawa holds a patent for the production of 2,6-diaminonebularines. This invention describes compounds detailed by the formula ##STR1## wherein R is phenyl, which may be substituted, or their acid addition salts. These compounds are produced in good yield through a reaction involving a specially prepared compound and a compound defined by formula ##STR3##, where protective groups on hydroxyls may be removed during processing.
Career Highlights
Yoichi Sawa works for Takeda Chemical Industries, Inc., a prestigious company known for its contributions to pharmaceutical development. His career at Takeda is marked by his dedication to research and innovation in creating life-changing pharmaceutical solutions.
Collaborations
Throughout his career, Sawa has collaborated with esteemed colleagues, including Masao Tsuda and Iwao Yamazaki. These collaborations have enriched his research endeavors and have contributed to the advancement of their shared fields.
Conclusion
With a focus on developing treatments for osteoporosis and producing essential chemicals, Yoichi Sawa exemplifies innovation in the scientific industry. His patents not only reflect his expertise but also his commitment to improving health outcomes through groundbreaking research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile